Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study

Tian, J; Wang, HD; Lu, CH; Liu, L; Zhang, XQ; Xie, YB; Li, RT; Lv, X; Fu, D; Zhang, L; Fang, XS; Wang, XM; Hu, J; Liu, XY; Huang, XC; Zhao, Q; Luo, N; Tang, H; Zhong, ZY; He, Y; Li, L

He, Y; Li, L (通讯作者),Third Mil Med Univ, Army Med Univ, Daping Hosp, Dept Resp Med, Chongqing 400042, Peoples R China.;Zhong, ZY (通讯作者),Third Mil Med Univ, Army Med Univ, Daping Hosp, Dept Canc Ctr, Chongqing, Peoples R China.

LUNG CANCER, 2023; 181 ():

Abstract

Background: Microsatellite instability (MSI) is the first pan-cancer biomarker approved to guide immune checkpoint inhibitor therapy for MSI-high (MSI......

Full Text Link